Navigation Links
Falcon Genomics Awarded Patent for Innovative Cancer Test

Patent Covers High-throughput, Anchorage-independent Assay for Screening Compounds for Inhibition of Cancer Cell Growth.

PITTSBURGH, May 28 /PRNewswire/ -- Falcon Genomics, Inc. announced today that it has received U.S. Patent # 7,537,913 with claims covering the Company's Cancer BioChip System (CBCS) for the identification and validation of potential cancer targets in a high-throughput in vitro setting with great clinical translational potential.

The patent claims are supported by experimental validation with human breast cancer cells using Falcon Genomics' first-generation Cancer BioChip System (CBC-1). These results, recently presented at the 6th Annual Conference on Cancer Drugs Research and Development in Philadelphia, PA (February 19, 2009) represent the first reported use of high-throughput one-step delivery of silencing RNA (siRNA) into cells growing in an anchorage-independent manner with real-time evaluation of cell growth.

"Cancer is analogous to a physiological train-wreck. It only takes a small number of defective signals to trigger the multitudes of abnormal molecular profiles observed within cancer cells. Triggering molecules are the ones that must be targeted for therapy," said Dr. Rula Abbud-Antaki, President and Chief Scientific Officer of Falcon Genomics. "Our proprietary technology will provide personalized identification of cancer- initiating events, and formulation of efficient and accurate therapies."

According to Dr. Peter D. Mlynek, a patent attorney with the law firm of Eckert Seamans, the Cancer BioChip System is a unique and highly useful technology. "The U.S. Patent Office has found the claimed CBCS to be novel and non-obvious."

About Falcon Genomics, Inc.

Falcon Genomics, Inc. is a private Pittsburgh-based biotech company founded in August 2004. The goal of the company is to provide cutting edge technologies, including functional genomics, for the accurate diagnosis of cancer patients and the personalized formulation of therapeutic strategies. Falcon Genomics currently provides CBCS services for research and pharmaceutical institutions working at the forefront of cancer diagnostics and therapeutics.

For more information, please visit:

SOURCE Falcon Genomics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
2. FalconStor Software Inc. Founders Make Multi-Million Dollar Donation to North Shore-LIJ Health System for Asian Community Health Center in Flushing
3. Atlanta Falcons Linebacker Keith Brooking Prepares to Run for Something Better at ING Georgia Marathon
4. MessageSolution and FalconStor Deliver Turnkey Solution for Enterprise Archiving, DR, and High-Availability
5. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
6. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
7. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
8. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
9. NeoGenomics Announces Results for the 3rd Quarter 2007
10. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
11. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2007 Healthcare Conference
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... TransPack Volume 6 features 30 customizable transitions ... scrolling web-styled transitions to wipes with blur & drop shadow options. Utilize the ... transition from one clip to the next with TransPack's easily customizable styles. ...
(Date:11/30/2015)... ... November 30, 2015 , ... Innovaacom, a leading ... results of a survey of educational needs for pharmacists worldwide. The poll of ... demand for high quality online and face-to-face education for pharmacists who are fast ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... partnership at the Radiological Society of North America (RSNA) 2015 conference. , ... cutting-edge dictation and speech-enabled documentation software, announced their partnership today at RSNA ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... 2016. In 2016, expected coding changes are likely to include new codes for ... It’s not easy to understand the effects of code changes in musculoskeletal, radiology ...
(Date:11/30/2015)... ... ... announced the introduction of three Nightstick® brand LED traffic wands with an average retail price ... ), yellow ( NSP-1634 ) and blue ( NSP-1636 ), the SL-1600 series LED traffic ... blinking strobe mode using a fresh set of 3 AAA cells (included). , Built to ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Royal Philips (NYSE: PHG AEX: PHIA) ... user interface and automatic scan parameter selection to help ... such as knee and hip replacements, spine implants and ... America Annual Meeting (RSNA) . The new software helps ... growing patient population. ScanWise Implant adds to Philips, suite ...
(Date:11/30/2015)... and BOCA RATON, Fla. , Nov. ... Commercialization of Public Research (the Institute) announced today ... KynderMed , a medical device start-up company with technology ... company creation based on publicly-funded research, and bridges early ... Florida -based universities and research institutions. ...
(Date:11/30/2015)... , Nov. 30, 2015 ... global biopharmaceutical leader dedicated to delivering transformative ... underserved medical conditions, today announced the launch ... (Recombinant), PEGylated], an extended circulating half-life recombinant ... based on full-length ADVATE [Antihemophilic Factor (Recombinant)]. ...
Breaking Medicine Technology: